type here...

Latest news

Clinical

Alector Ends Development of GSK-Partnered Latozinemab After Phase 3 Failure in FTD

Key Takeaways: Alector is discontinuing the development of latozinemab for frontotemporal dementia (FTD) after it failed to meet its...
Regulatory

FDA Expands Rybelsus Approval to Reduce Cardiovascular Risk in Type 2 Diabetes Patients

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s oral semaglutide therapy Rybelsus to lower the risk...
Regulatory

FDA Approves Roche’s Gazyva for Treatment of Active Lupus Nephritis

FDA Approves New Treatment for Lupus Nephritis Roche has received U.S. Food and Drug Administration (FDA) approval for its medicine...
Manufacturing

Merck expands once more as part of a planned $70 billion US investment

Merck's New Virginia Plant Merck has launched a new $3 billion plant on its large manufacturing campus in Elkton, Virginia....
Clinical

Tvardi Therapeutics Reports Phase 2 Failure for IPF Drug Candidate TTI-101

Phase 2 Trial Fails to Meet Objectives Drug development efforts...
Regulatory

BioCryst Pens $700M Deal to Acquire Astria, Strengthening Rare Disease Focus

Major Acquisition in Rare Disease Space BioCryst Pharmaceuticals, which has...
Regulatory

Kailera Therapeutics Secures $600 Million Series B to Advance Global Obesity Drug Program

Kailera Therapeutics Secures Major Funding Kailera Therapeutics has raised $600 million in a Series B financing to support the advancement...
Commercial

Johnson & Johnson to Spin Off Orthopedics Business as DePuy Synthes in 18 to 24 Months

A New Chapter for J&J's Orthopedics Division Johnson & Johnson (J&J) has announced plans to separate its orthopedics division into...
Manufacturing

LTS Lohmann Acquires Renaissance Lakewood to Expand U.S. CDMO Capabilities

German pharmaceutical technology company LTS Lohmann is expanding its operations in the United States through the acquisition of Renaissance...
Regulatory

Regeneron Reports New Data on Gene Therapy for Hearing Loss, Advances CHORD Trial Toward FDA Submission

DB-OTO Gene Therapy Shows Promise in Restoring Hearing Regeneron Pharmaceuticals...
Clinical

Moderna Reveals Promising Melanoma Data Behind Decision to Proceed With Cancer Candidate

Promising Early Results Moderna has released early clinical data that...
Commercial

AviadoBio Secures Option for $413 Million Gene Therapy Deal with UgeneX for Rare Eye Diseases

A Landmark Partnership in Gene Therapy AviadoBio has obtained an exclusive option for a gene therapy targeting rare eye diseases...
Commercial

Novo Pens $5.2B Deal to Acquire Akero, Entering Liver Disease Space

The Agreement Novo Nordisk has agreed to acquire Akero Therapeutics in a deal valued at $5.2 billion, marking another major...
Regulatory

FDA Approves Regeneron’s Libtayo for High-Risk Skin Cancer as Adjuvant Therapy

New Hope for High-Risk Skin Cancer Patients The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals’ Libtayo (cemiplimab)...
Commercial

Philips and Masimo Extend Partnership for Patient Monitoring Technologies

Strategic Renewal Philips and Masimo have renewed their multi-year strategic...
Commercial

AstraZeneca Acquires Amolyt Pharma, Expanding into Rare Endocrinology

AstraZeneca has made a strategic move into the realm...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

FDA Expands Rybelsus Approval to Reduce Cardiovascular Risk in Type 2 Diabetes Patients

The U.S. Food and Drug Administration (FDA) has approved...
Regulatory

FDA Approves Roche’s Gazyva for Treatment of Active Lupus Nephritis

FDA Approves New Treatment for Lupus Nephritis Roche has received...
Manufacturing

Merck expands once more as part of a planned $70 billion US investment

Merck's New Virginia Plant Merck has launched a new $3...
Regulatory

FDA Gives Green Light to Glaukos’ Eye Disorder Therapy

Understanding Keratoconus The FDA has approved Glaukos’ corneal treatment, Epioxa,...

Research & Development

Market Access

Manufacturing

Generation Bio Lays Off 90% of Workforce Amid Funding Challenges for Autoimmune Drug Delivery Technology

Massachusetts-based biotech company Generation Bio has announced a massive...
Manufacturing

Philips to Invest Over $150 Million in Expanding U.S. Manufacturing and R&D

Philips has announced it will invest more than $150...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Clinical

Alector Ends Development of GSK-Partnered Latozinemab After Phase 3 Failure in FTD

Key Takeaways: Alector is discontinuing the development of latozinemab...
Editotial Team -
Manufacturing

LTS Lohmann Acquires Renaissance Lakewood to Expand U.S. CDMO Capabilities

German pharmaceutical technology company LTS Lohmann is expanding its...
Editotial Team -
Regulatory

FDA Approves Roche’s Gazyva for Treatment of Active Lupus Nephritis

FDA Approves New Treatment for Lupus Nephritis Roche has received...
Editotial Team -

Editor Picks

Must Read

Hot Topics

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

© Copyright - Life Sciences Voice